BC
Bayforest Capital Portfolio holdings
AUM
$229M
This Quarter Return
+10.59%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$229M
AUM Growth
-$725K
(-0.32%)
Cap. Flow
-$16.3M
Cap. Flow
% of AUM
-7.12%
Top 10 Holdings %
Top 10 Hldgs %
6.28%
Holding
939
New
227
Increased
220
Reduced
265
Closed
227
Top Buys
| 1 |
Service Corp International
SCI
|
$1.42M |
| 2 |
Charter Communications
CHTR
|
$1.25M |
| 3 |
Harley-Davidson
HOG
|
$1.22M |
| 4 |
TechnipFMC
FTI
|
$1.19M |
| 5 |
ScottsMiracle-Gro
SMG
|
$1.16M |
Top Sells
| 1 |
Palantir
PLTR
|
$2.24M |
| 2 |
Bloom Energy
BE
|
$2.06M |
| 3 |
Moelis & Co
MC
|
$1.78M |
| 4 |
Signet Jewelers
SIG
|
$1.48M |
| 5 |
First Majestic Silver
AG
|
$1.43M |
Sector Composition
| 1 | Technology | 18.75% |
| 2 | Consumer Discretionary | 15.59% |
| 3 | Financials | 11.82% |
| 4 | Industrials | 11.64% |
| 5 | Healthcare | 11.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Twilio
TWLO
$16.7B
| $266K | 0.12% |
2,140
-2,035
| -49% | -$253K |
|
327
T-Mobile US
TMUS
$284B
| $258K | 0.11% |
1,083
+588
| +119% | +$140K |
|
328
ICU Medical
ICUI
$3.24B
| $257K | 0.11% |
+1,942
| New | +$257K |
|
329
UDR
UDR
$13B
| $256K | 0.11% |
6,275
+862
| +16% | +$35.2K |
|
330
Adtalem Global Education
ATGE
$4.83B
| $255K | 0.11% |
+2,007
| New | +$255K |
|
331
Lantheus
LNTH
$3.72B
| $255K | 0.11% |
3,111
+1,269
| +69% | +$104K |
|
332
WD-40
WDFC
$2.95B
| $253K | 0.11% |
1,111
-900
| -45% | -$205K |
|
333
Conagra Brands
CAG
$9.23B
| $248K | 0.11% |
12,135
-1,192
| -9% | -$24.4K |
|
334
Takeda Pharmaceutical
TAK
$48.6B
| $247K | 0.11% |
+16,005
| New | +$247K |
|
335
Consolidated Edison
ED
$35.4B
| $247K | 0.11% |
2,462
-7
| -0.3% | -$702 |
|
336
General Dynamics
GD
$86.8B
| $246K | 0.11% |
+843
| New | +$246K |
|
337
J.M. Smucker
SJM
$12B
| $245K | 0.11% |
+2,492
| New | +$245K |
|
338
Telephone and Data Systems
TDS
$4.54B
| $245K | 0.11% |
6,876
+5,534
| +412% | +$197K |
|
339
Illumina
ILMN
$15.7B
| $244K | 0.11% |
2,555
-503
| -16% | -$48K |
|
340
Boston Scientific
BSX
$159B
| $243K | 0.11% |
2,263
+1,893
| +512% | +$203K |
|
341
GSK
GSK
$81.6B
| $243K | 0.11% |
+6,324
| New | +$243K |
|
342
BioMarin Pharmaceuticals
BMRN
$11.1B
| $239K | 0.1% |
4,352
-3,456
| -44% | -$190K |
|
343
Twist Bioscience
TWST
$1.55B
| $238K | 0.1% |
6,480
+1,620
| +33% | +$59.6K |
|
344
Bio-Techne
TECH
$8.46B
| $238K | 0.1% |
4,628
+56
| +1% | +$2.88K |
|
345
Hartford Financial Services
HIG
$37B
| $237K | 0.1% |
1,869
-1,215
| -39% | -$154K |
|
346
Commault Systems
CVLT
$7.96B
| $235K | 0.1% |
1,349
+1,125
| +502% | +$196K |
|
347
Asana
ASAN
$3.18B
| $235K | 0.1% |
17,414
-3,200
| -16% | -$43.2K |
|
348
Ashland
ASH
$2.51B
| $234K | 0.1% |
+4,644
| New | +$234K |
|
349
Allstate
ALL
$53.1B
| $231K | 0.1% |
1,148
-489
| -30% | -$98.4K |
|
350
Nucor
NUE
$33.8B
| $229K | 0.1% |
+1,765
| New | +$229K |
|